InspireMD (NSPR) Misses Q3 EPS by 1c

InspireMD (NASDAQ: NSPR) reported Q3 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.5 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Accenture tumbles 16% on guidance cut; announces Dragos, runZero, NetRise deals
• JPMorgan Upgrades YDUQS Participacoes SA (YDUQ3:BZ) to Overweight